Shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $206.86, but opened at $221.39. Direxion Daily S&P Biotech Bull 3x Shares shares last traded at $228.66, with a volume of 313,538 shares traded.
Direxion Daily S&P Biotech Bull 3x Shares Stock Up 10.9%
The company has a 50 day moving average price of $183.93 and a 200-day moving average price of $171.36.
Hedge Funds Weigh In On Direxion Daily S&P Biotech Bull 3x Shares
Institutional investors and hedge funds have recently bought and sold shares of the stock. Covestor Ltd bought a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter worth about $71,000. Qube Research & Technologies Ltd bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the second quarter valued at approximately $26,000. Halbert Hargrove Global Advisors LLC acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the first quarter valued at approximately $166,000. Headlands Technologies LLC acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the second quarter valued at approximately $69,000. Finally, Bank of America Corp DE increased its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 134.2% during the third quarter. Bank of America Corp DE now owns 2,476 shares of the company’s stock valued at $232,000 after acquiring an additional 1,419 shares during the period.
Direxion Daily S&P Biotech Bull 3x Shares Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Featured Stories
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
- 5 Stocks Solving the AI Power Crisis
- 3 Oil Refiners Built to Cash In on Higher Crack Spreads
- Microsoft’s Boring Stock Story May Be Its Biggest Strength
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
